Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema

NCT01343823 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01343823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01343823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Lead sponsor
Shire
Phase
Phase 2
Overall status
Terminated
Start date
June 1, 2011
Completion date
June 1, 2012
Enrollment
79 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

ace inhibitor induced angioedema